5 Reasons Celgene Corporation Is a Buy
Celgene has been a monster stock for investors, and this Fool thinks the future continues to look bright. Here are five reasons Celgene is a buy today.
Celgene Buys Receptos. Is Arena Pharmaceuticals Next?
Both biotechs have S1P1 receptor drugs, but they're not created equal.
3 Questions Investors Should Ask When Celgene Reports Its Second-Quarter Results
Celgene's Q2 report is right around the corner. Here are three questions investors should keep in mind.